SS Innovations International, Inc. (SSII)
Health Care · Surgical robotics and minimally invasive surgical devices · Nasdaq
SS Innovations develops and markets robotic surgical systems for minimally invasive procedures, growing rapidly but currently unprofitable.
What SS Innovations International, Inc. does
SS Innovations International manufactures and sells robotic surgical systems, instruments, and related devices for minimally invasive surgery. The company generates revenue through system sales, instruments, warranty services, and lease arrangements. It operates manufacturing and headquarters facilities in Gurugram, India, and serves healthcare providers globally seeking advanced surgical technology.
Themes: ["Robotic surgery / surgical robots","Minimally invasive surgery","Medical device manufacturing","Healthcare technology"]
Fundamentals
- Price$3.79 as of 2026-07-10 close
- Market cap$758M as of 2026-07-13
- 1-year return-29.3% as of 2026-07-10 close
- Net margin-20.7% as of 2026-07-13
- Gross margin+49.1% as of 2026-07-13
- ROE-23.0% as of 2026-07-13
- Debt / equity0.20 as of 2026-07-13
- Revenue growth (YoY)+42.6% as of 2026-07-13
- Revenue CAGR (3y)+209.3% SEC XBRL
- Beta-78.28 as of 2026-07-13
Key risks (from latest filing)
["Company is unprofitable with negative net margin of -20.69% and sustained operating losses; Q1 2026 net loss of $3.6M despite 42.6% YoY revenue growth","Stock price declined 29.3% over the past year, indicating investor concern over pathway to profitability and execution risk","Significant litigation exposure including 2024 judgment of $296,000 plus interest regarding alleged alter ego liability from prior company (Avra Surgical); ongoing legal risks could divert resources"]
Competitors & peers
Fundamentals: Finnhub, as of 2026-07-13. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-10.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.